COYA
Coya Therapeutics, Inc. NASDAQ Listed Dec 29, 2022$4.20
Mkt Cap $70.3M
52w Low $3.71
12.1% of range
52w High $7.75
50d MA $4.43
200d MA $5.44
P/E (TTM)
-3.3x
EV/EBITDA
-2.5x
P/B
1.6x
Debt/Equity
0.0x
ROE
-49.3%
P/FCF
-9.0x
RSI (14)
—
ATR (14)
—
Beta
0.52
50d MA
$4.43
200d MA
$5.44
Avg Volume
143.3K
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination for subcutaneous and/or intravenous administration intended to enhance Treg function while depleting T effector function and activated macrophages for use in the treatment of neurodegenerative and autoimmune diseases. It is also developing COYA 201, an allogeneic Treg exosome product candidate that is in preclinical stage for use in the treatment of neurodegenerative, autoimmune, and metabolic diseases; and COYA 206, an antigen directed Treg-derived exosome product candidate, which is in discovery stage. The company was incorporated in 2020 and is headquartered in Houston, Texas.
5850 San Felipe Street · Houston, TX 77057 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | AMC | -0.27 | -0.34 | -24.8% | 4.50 | +0.7% | -2.2% | +1.1% | -4.0% | -1.4% | +0.2% | — |
| Nov 12, 2025 | AMC | 0.02 | -0.10 | -600.0% | 6.09 | +0.2% | -2.1% | -1.5% | -0.3% | +5.3% | -6.0% | — |
| Aug 12, 2025 | AMC | -0.22 | -0.36 | -63.6% | 6.13 | +0.2% | +1.1% | -8.2% | +8.1% | -2.3% | -1.2% | — |
| May 13, 2025 | AMC | -0.44 | -0.44 | +0.0% | 5.76 | +2.4% | -1.2% | +3.2% | +1.0% | +0.7% | -1.8% | — |
| Mar 18, 2025 | AMC | -0.26 | -0.18 | +30.8% | 6.45 | +2.0% | +0.0% | +0.3% | +3.2% | -0.4% | -1.5% | — |
| Nov 6, 2024 | AMC | -0.41 | -0.26 | +36.6% | 7.26 | +1.4% | -0.6% | -0.1% | +1.7% | -1.1% | -0.1% | — |
| Aug 12, 2024 | AMC | -0.14 | -0.19 | -35.7% | 5.28 | -3.4% | -2.7% | -6.2% | +3.9% | +2.2% | +9.8% | — |
| May 9, 2024 | AMC | -0.30 | -0.35 | -16.7% | 8.46 | +3.0% | -3.0% | -1.6% | +2.1% | +1.8% | +1.2% | — |
| Mar 19, 2024 | AMC | 0.26 | 0.15 | -42.3% | 10.07 | +2.6% | -1.1% | -0.5% | -1.9% | -8.8% | -0.1% | — |
| Nov 8, 2023 | AMC | -0.37 | -0.34 | +8.1% | 5.09 | +0.0% | -5.5% | +5.0% | -0.8% | +1.4% | -1.4% | — |
| Aug 8, 2023 | AMC | -0.32 | -0.31 | +3.1% | 3.90 | +1.5% | -2.6% | -2.6% | -8.6% | +4.5% | -3.2% | — |
| May 10, 2023 | AMC | -0.43 | -0.28 | +34.9% | 5.35 | -3.7% | -3.7% | +1.7% | +1.1% | +10.0% | -1.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10 | D. Boral Capital | Maintains | Buy → Buy | — | $4.53 | $4.54 | +0.2% | -7.9% | +6.7% | +0.2% | +1.6% | -1.1% |
| Mar 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.21 | $4.23 | +0.5% | +0.2% | -1.7% | +1.2% | -0.5% | -5.3% |
| Mar 19 | D. Boral Capital | Maintains | Buy → Buy | — | $4.45 | $4.48 | +0.7% | -4.0% | -1.4% | +0.2% | -1.7% | +1.2% |
| Mar 16 | Chardan Capital | Maintains | Buy → Buy | — | $4.53 | $4.46 | -1.5% | -0.7% | -2.2% | +1.1% | -4.0% | -1.4% |
| Mar 16 | D. Boral Capital | Maintains | Buy → Buy | — | $4.53 | $4.46 | -1.5% | -0.7% | -2.2% | +1.1% | -4.0% | -1.4% |
| Feb 18 | D. Boral Capital | Maintains | Buy → Buy | — | $4.65 | $4.61 | -0.9% | +4.3% | +0.0% | -4.9% | +1.5% | +4.7% |
| Feb 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.65 | $4.62 | -0.6% | +1.9% | +2.5% | -2.1% | -7.1% | +9.5% |
| Jan 21 | D. Boral Capital | Maintains | Buy → Buy | — | $4.48 | $4.48 | +0.0% | +1.6% | +4.0% | -0.2% | -0.8% | +3.4% |
| Jan 8 | D. Boral Capital | Maintains | Buy → Buy | — | $5.15 | $5.15 | +0.0% | -0.6% | -5.3% | -2.1% | -2.7% | +0.4% |
| Jan 8 | Chardan Capital | Maintains | Buy → Buy | — | $5.15 | $5.15 | +0.0% | -0.6% | -5.3% | -2.1% | -2.7% | +0.4% |
| Jan 5 | D. Boral Capital | Maintains | Buy → Buy | — | $5.65 | $5.75 | +1.8% | -5.1% | -2.1% | -1.9% | -0.6% | -5.3% |
| Dec 23 | D. Boral Capital | Maintains | Buy → Buy | — | $5.36 | $5.69 | +6.2% | +0.6% | +3.0% | -1.4% | +1.5% | -0.2% |
| Dec 9 | D. Boral Capital | Maintains | Buy → Buy | — | $6.07 | $6.15 | +1.3% | +1.2% | -0.8% | +2.6% | -1.1% | -4.4% |
| Nov 14 | Chardan Capital | Maintains | Buy → Buy | — | $5.96 | $5.86 | -1.7% | -1.5% | -0.3% | +5.3% | -6.0% | +3.3% |
| Nov 13 | BTIG | Maintains | Buy → Buy | — | $6.09 | $6.10 | +0.2% | -2.1% | -1.5% | -0.3% | +5.3% | -6.0% |
| Nov 12 | D. Boral Capital | Maintains | Buy → Buy | — | $6.01 | $6.04 | +0.5% | +1.3% | -2.1% | -1.5% | -0.3% | +5.3% |
| Sep 30 | BTIG | Maintains | Buy → Buy | — | $5.66 | $5.68 | +0.4% | +0.7% | +2.6% | +0.3% | +3.9% | +6.6% |
| Sep 29 | D. Boral Capital | Maintains | Buy → Buy | — | $5.49 | $5.57 | +1.5% | +3.1% | +0.7% | +2.6% | +0.3% | +3.9% |
| Sep 22 | D. Boral Capital | Maintains | Buy → Buy | — | $5.50 | $5.53 | +0.5% | -0.5% | -4.0% | +5.9% | -4.5% | +3.4% |
| Sep 17 | D. Boral Capital | Maintains | Buy → Buy | — | $5.67 | $5.70 | +0.5% | -4.6% | +6.1% | -4.2% | -0.5% | -4.0% |
| Sep 17 | Chardan Capital | Maintains | Buy → Buy | — | $5.67 | $5.70 | +0.5% | -4.6% | +6.1% | -4.2% | -0.5% | -4.0% |
| Sep 4 | D. Boral Capital | Maintains | Buy → Buy | — | $6.69 | $6.80 | +1.6% | -4.6% | -1.7% | +1.6% | -1.6% | +0.6% |
| Aug 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.73 | $6.80 | +1.0% | -2.5% | +2.3% | -2.2% | -0.6% | +2.6% |
| Aug 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.86 | $7.15 | +4.2% | -5.2% | +3.5% | -2.5% | +2.3% | -2.2% |
| Aug 25 | D. Boral Capital | Maintains | Buy → Buy | — | $6.86 | $7.15 | +4.2% | -5.2% | +3.5% | -2.5% | +2.3% | -2.2% |
| Aug 13 | Chardan Capital | Maintains | Buy → Buy | — | $6.13 | $6.14 | +0.2% | +1.1% | -8.2% | +8.1% | -2.3% | -1.2% |
| Aug 13 | D. Boral Capital | Maintains | Buy → Buy | — | $6.13 | $6.14 | +0.2% | +1.1% | -8.2% | +8.1% | -2.3% | -1.2% |
| Jul 24 | D. Boral Capital | Maintains | Buy → Buy | — | $6.07 | $6.08 | +0.2% | +10.7% | -0.7% | -0.7% | -3.3% | -8.3% |
| Jul 1 | Chardan Capital | Maintains | Buy → Buy | — | $5.75 | $5.79 | +0.7% | -0.9% | +1.4% | +3.1% | -1.5% | +2.2% |
| Jun 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.88 | $6.03 | +2.6% | +0.0% | -4.3% | +0.0% | -4.6% | +4.8% |
| May 13 | Chardan Capital | Maintains | Buy → Buy | — | $6.14 | $6.12 | -0.3% | -6.2% | -1.2% | +3.2% | +1.0% | +0.7% |
| Apr 28 | Chardan Capital | Maintains | Buy → Buy | — | $6.18 | $6.18 | +0.0% | -0.2% | -1.1% | +8.0% | -4.7% | +1.4% |
| Apr 24 | D. Boral Capital | Maintains | Buy → Buy | — | $6.56 | $6.83 | +4.1% | -0.5% | -5.4% | -0.2% | -1.1% | +8.0% |
| Apr 22 | D. Boral Capital | Maintains | Buy → Buy | — | $5.71 | $5.82 | +1.9% | +16.3% | -1.2% | -0.5% | -5.4% | -0.2% |
| Mar 27 | D. Boral Capital | Maintains | Buy → Buy | — | $6.51 | $6.60 | +1.4% | +5.8% | -4.8% | -1.4% | -2.5% | +3.6% |
| Mar 20 | Chardan Capital | Maintains | Buy → Buy | — | $6.45 | $6.31 | -2.2% | +0.3% | +3.2% | -0.4% | -1.5% | -0.6% |
| Mar 18 | D. Boral Capital | Maintains | Buy → Buy | — | $6.85 | $6.98 | +1.9% | -5.8% | +0.0% | +0.3% | +3.2% | -0.4% |
| Mar 10 | D. Boral Capital | Maintains | Buy → Buy | — | $6.88 | $6.92 | +0.6% | -4.9% | +2.4% | -1.0% | -2.3% | +0.2% |
| Feb 6 | D. Boral Capital | Maintains | Buy → Buy | — | $6.53 | $7.10 | +8.7% | +7.2% | -2.4% | +0.7% | -3.6% | -0.3% |
| Feb 6 | Chardan Capital | Maintains | Buy → Buy | — | $6.53 | $7.10 | +8.7% | +7.2% | -2.4% | +0.7% | -3.6% | -0.3% |
| Jan 21 | D. Boral Capital | Maintains | Buy → Buy | — | $5.38 | $5.50 | +2.2% | +5.2% | +0.0% | +3.2% | +1.0% | -0.2% |
| Dec 18 | D. Boral Capital | Maintains | Buy → Buy | — | $5.61 | $5.65 | +0.7% | -7.1% | -1.0% | +1.6% | +1.3% | +2.1% |
| Nov 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.21 | $7.15 | -0.8% | +1.7% | -1.1% | -0.1% | -5.9% | -7.2% |
| Nov 7 | Chardan Capital | Maintains | Buy → Buy | — | $7.26 | $7.36 | +1.4% | -0.6% | -0.1% | +1.7% | -1.1% | -0.1% |
| Oct 30 | Chardan Capital | Maintains | Buy → Buy | — | $7.37 | $7.02 | -4.7% | -9.6% | +8.6% | -2.6% | -2.7% | -1.6% |
| Jun 5 | Chardan Capital | Maintains | Buy → Buy | — | $7.45 | $7.56 | +1.5% | -6.6% | +0.3% | +3.0% | -1.3% | +12.7% |
| May 9 | Chardan Capital | Maintains | Buy → Buy | — | $8.03 | $7.87 | -2.0% | +5.4% | -3.0% | -1.6% | +2.1% | +1.8% |
| Apr 29 | Chardan Capital | Maintains | Buy → Buy | — | $8.60 | $8.55 | -0.6% | -2.6% | +8.0% | -4.2% | +1.3% | -1.1% |
| Mar 20 | Chardan Capital | Maintains | Buy → Buy | — | $10.07 | $10.33 | +2.6% | -1.1% | -0.5% | -1.9% | -8.8% | -0.1% |
| Aug 9 | Chardan Capital | Maintains | Buy → Buy | — | $3.90 | $3.96 | +1.5% | -2.6% | -2.6% | -8.6% | +4.5% | -3.2% |
No insider trades available.
8-K · 8.01
!! High
Coya Therapeutics, Inc. -- 8-K 8.01: Material Event / Announcement
May 12
8-K · 1.01
!! High
Coya Therapeutics, Inc. -- 8-K 1.01: Material Agreement
May 12
8-K
Unknown — 8-K Filing
The company resolved a management departure cleanly without additional financial obligations, protecting it from litigation risk and reducing severance costs beyond contractual minimums.
Apr 2
8-K
Unknown — 8-K Filing
Coya Therapeutics reported FY2025 results and provided a corporate update, which investors should review for revenue trends, cash position, and pipeline progress to assess the biotech's financial runway and clinical development momentum.
Mar 16
Data updated apr 25, 2026 2:46am
· Source: massive.com